| Literature DB >> 33848474 |
Evan Lester1, Felicia K Ooi2, Nadine Bakkar3, Jacob Ayers4, Amanda L Woerman5, Joshua Wheeler6, Robert Bowser3, George A Carlson4, Stanley B Prusiner7, Roy Parker8.
Abstract
Tau aggregates contribute to neurodegenerative diseases, including frontotemporal dementia and Alzheimer's disease (AD). Although RNA promotes tau aggregation in vitro, whether tau aggregates in cells contain RNA is unknown. We demonstrate, in cell culture and mouse brains, that cytosolic and nuclear tau aggregates contain RNA with enrichment for small nuclear RNAs (snRNAs) and small nucleolar RNAs (snoRNAs). Nuclear tau aggregates colocalize with and alter the composition, dynamics, and organization of nuclear speckles, membraneless organelles involved in pre-mRNA splicing. Moreover, several nuclear speckle components, including SRRM2, mislocalize to cytosolic tau aggregates in cells, mouse brains, and brains of individuals with AD, frontotemporal dementia (FTD), and corticobasal degeneration (CBD). Consistent with these alterations, we observe that the presence of tau aggregates is sufficient to alter pre-mRNA splicing. This work identifies tau alteration of nuclear speckles as a feature of tau aggregation that may contribute to the pathology of tau aggregates.Entities:
Keywords: Alzheimer's Disease; Frontemporal Dementia; MAPT; Nuclear Speckles; RNA; RNA binding proteins; SRRM2; Splicing; Tau; snRNA
Mesh:
Substances:
Year: 2021 PMID: 33848474 PMCID: PMC8141031 DOI: 10.1016/j.neuron.2021.03.026
Source DB: PubMed Journal: Neuron ISSN: 0896-6273 Impact factor: 17.173